StockVS

AI Financial Corporation (ALTS) Aandelenanalyse

Technologie

AI Financial Corporation

$0.80

$-0.09 (-10.11%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

ALT5 Sigma Corporation is a specialized entity that delivers blockchain-powered technologies on a global scale, operating specifically through its Fintech and Biotechnology segments to facilitate the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company functions within the Technology sector, focusing on the Software - Application industry, which implies a reliance on intellectual property and rapid technological iteration rather than traditional manufacturing or service delivery models. According to current market data, ALT5 Sigma Corporation holds a market capitalization of $118.76M and generates annual revenue of $24.89M, while employing a workforce of only 10 individuals. These valuation and revenue figures indicate that the company operates as a micro-cap entity with a highly concentrated operational structure, suggesting that its entire market value is supported by a minimal headcount and a specific niche in the digital asset infrastructure space.

Financiële gezondheid

The company reported revenue of $24.89M over the trailing twelve months, accompanied by a net income of $33.67M and an EBITDA of $-18,142,000. The significant discrepancy between the reported net income and the negative EBITDA reveals a complex cost structure where non-operating income or accounting adjustments, such as the recognition of asset gains or tax benefits, are inflating the bottom line while underlying cash-generating operations remain negative. Free cash flow stands at $-10,371,375, which indicates that the company is currently consuming cash to fund its operations or growth initiatives rather than generating excess liquidity for debt repayment or shareholder distributions. The gross margin is recorded at 43.5%, reflecting the company's ability to retain a substantial portion of revenue after direct costs, yet the operating margin is severely depressed at -218.3%, signaling that operating expenses are more than double the revenue generated. Profit margin stands at 133.1%, a figure that suggests the net income exceeds total revenue, likely due to one-time gains or non-operating credits that distort the traditional view of profitability. On the balance sheet, the company holds $7.32M in cash against $17.81M in debt, resulting in a debt-to-equity ratio of 1.14, which characterizes the entity as highly leveraged relative to its equity base. The current ratio is 0.80, indicating that current assets are insufficient to cover current liabilities without relying on external financing or asset liquidation. Return on Equity is 4.3%, while Return on Assets is -1.7%, metrics that collectively reveal that management is not effectively utilizing the company's capital base to generate returns, as the assets employed are generating a negative return on the total asset pool.

Waarderingsbeoordeling

Trailing P/E and forward P/E are both listed as N/A, which implies that the market cannot value the stock based on traditional earnings multiples due to the irregularity of reported earnings or the specific nature of the company's financial reporting structure. The price-to-book ratio is 0.08, indicating that the market values the company at a fraction of its net asset book value, suggesting a significant market discount or a lack of confidence in the recoverability of the company's assets. The price-to-sales ratio is 4.77, a metric that is notably high for a company with a negative operating margin, suggesting that the market is pricing in future growth expectations rather than current profitability. The EV/EBITDA multiple is -8.46, a negative figure that reflects the company's negative earnings before interest, taxes, depreciation, and amortization, making traditional enterprise value comparisons with profitable peers difficult. The 52-week high is $10.95 and the 52-week low is $0.94; without a specific current price provided in the facts, the relative trading position cannot be calculated, but the range demonstrates extreme volatility within a single trading year. The beta value is 2.01, which means the stock is expected to be twice as volatile as the broader market, exposing investors to significantly higher price swings during periods of market turbulence.

Growth & Income

Revenue growth year-over-year is 53.3%, while earnings growth is listed as N/A, indicating that the company is expanding its top line rapidly but has not yet established consistent, repeatable earnings growth patterns. The absence of a consistent earnings growth rate relative to revenue suggests that the company's profitability is currently dependent on non-recurring items or has not yet stabilized into a predictable operational rhythm. As the dividend yield is N/A and the payout ratio is 0.0%, the company does not distribute cash to shareholders, implying that all generated cash is being retained and reinvested into the business or used to service its debt obligations. The overall growth and income profile for ALT5 Sigma Corporation is characterized by high revenue expansion coupled with negative cash flows and no dividend distribution, presenting a high-risk, high-potential-reward scenario typical of early-stage technology firms that prioritize capital allocation for growth over shareholder returns.

Vergelijking met sectorgenoten

AI Financial Corporation (ALTS) is actief in de Software - Applicatie-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
AI Financial Corporation ALTS $119.56M N/A
SAP SE SAP $206.49B 24.1
Shopify Inc. SHOP.TO $188.02B 102.8
Salesforce, Inc. CRM $146.50B 22.9

De gemiddelde K/W-verhouding in de Software - Applicatie-sector is 45.6x. AI Financial Corporation wordt verhandeld tegen een K/W van N/A.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over AI Financial Corporation

ALT5 Sigma Corporation, together with its subsidiaries, provides blockchain-powered technologies worldwide. It operates through Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. Its products include ALT 5 Prime, an electronic over-the-counter trading platform for the buying and selling of digital assets; and ALT 5 Pay, a crypto-currency payment gateway that enables merchants to accept and make crypto currency payments or integrate the payment platform into their application. The company is also involved identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies for the treatment of pain and addiction. In addition, it develops JAN 101, an oral and sustained-release pharmaceutical composition of sodium nitrite that has completed Phase 2a clinical trial to treat peripheral arterial disease and pain; and JAN123, a formulation of low-dose naltrexone for the treatment of chronic regional pain syndrome. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$119.56M
K/W-verhouding
N/A
52-weken hoog
$10.95
52-weken laag
$0.73
Gem. Volume
2.79M
Bèta
2.01

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States
Werknemers
15